Simethicone 80mg

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of gas distress, bloating, and discomfort.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults should chew 1 or 2 tablets completely as needed after meals and at bedtime. It is important that the tablets are not swallowed whole. The maximum recommended dosage is 6 tablets within a 24-hour period, unless otherwise directed by a physician.

Contraindications

There are no contraindications listed for this product. It is important to evaluate individual patient circumstances and consult relevant clinical guidelines when considering its use.

Warnings and Precautions

Healthcare professionals should be aware of the critical importance of immediate medical intervention in cases of suspected overdose or adverse reactions. In such situations, it is imperative to seek medical assistance or contact a poison control center without delay. The national poison control hotline can be reached at 1-800-222-1222 for guidance and support.

It is essential to monitor patients closely for any signs of adverse effects or complications associated with the use of this medication. Regular assessments and appropriate laboratory tests should be conducted as indicated to ensure patient safety and effective management of any potential risks.

Side Effects

Patients should be aware that in the event of an adverse reaction, immediate medical assistance is crucial. It is recommended to contact a medical professional or reach out to a poison control center at 1-800-222-1222 without delay. This guidance is essential for ensuring prompt and appropriate care in the case of serious reactions.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Simethicone 80mg (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored when medications are administered, as safety and efficacy in this population can vary. It is crucial to keep all medications, including this product, out of the reach of children to prevent accidental ingestion.

This Unit Dose package is not child resistant and is intended for institutional use only. Healthcare professionals should ensure that this product is stored securely and that appropriate precautions are taken to prevent access by pediatric patients.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled on the absence of established safety information and the importance of discussing any potential pregnancy with their healthcare provider.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any considerations related to lactation. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to seek immediate medical assistance or contact a poison control center. Healthcare professionals should advise patients or caregivers to call the National Capital Poison Center at 1-800-222-1222 for expert guidance.

Prompt intervention is crucial in managing overdosage situations. Symptoms may vary depending on the substance involved, and healthcare providers should be prepared to assess and address any potential complications that may arise.

Management procedures should include a thorough evaluation of the patient's condition, monitoring vital signs, and providing supportive care as necessary. Depending on the specific circumstances of the overdosage, additional treatments may be warranted to mitigate adverse effects.

It is essential for healthcare professionals to remain vigilant and act swiftly to ensure the safety and well-being of the patient in cases of suspected overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the potential risks associated with improper access to the medication, ensuring that patients understand the necessity of safeguarding it in their home environment.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted, ensuring straightforward management within standard storage conditions.

Additional Clinical Information

The medication is administered orally, with adults instructed to chew 1 or 2 tablets completely as needed after meals and at bedtime. It is important that patients do not swallow the tablets whole and do not exceed 6 tablets within a 24-hour period unless advised and supervised by a physician.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Simethicone 80mg, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)